Answers are grounded in this paper and cite their sources.
Systematic review finds reduced tumor growth with nutritional supplementation in animal models, suggesting therapeutic potential.
Breast cancer remains the most prevalent malignancy among women worldwide, and experimental tumor models are essential for evaluating new therapeutic approaches before clinical application. The Walker-256 carcinoma model exhibits biological behavior comparable to human carcinoma and allows short-term assessment of tumor progression. This study aimed to conduct a systematic review and meta-analysis of the effects of dietary supplementation on Walker-256 tumor growth. We followed the PRISMA guidelines and searched the PubMed, Embase, and Cochrane databases without time restrictions. The meta-analysis included clustering based on the type of supplementation received, comparing treatment groups with control groups. Twenty-one studies were included, analyzing 18 different supplements, and 12 studies were considered for quantitative synthesis. The overall effect indicated a significant reduction in tumor growth with supplementation (SMD = 3.286; 95% CI: 2.546–4.027; p < 0.001), despite high heterogeneity (I2 = 98.6%). Oils had the greatest impact, particularly fish oil (SMD = 7.368; 95% CI: 3.606–11.131) and shark liver oil (SMD = 5.781; 95% CI: 3.655–7.907), followed by amino acids and linoleic acid-rich supplements. We conclude that nutritional supplementation may have the potential to reduce tumor growth in Walker-256 models.
No takes yet. Share an insight, caveat, or question.
Ribeiro-Silva et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: